If a patient is experiencing side effects, dose titration should occur more slowly and if side effects are severe, the dose should be reduced back to the dose that was tolerated
GIP (Glucose-Dependent Insulinotropic Polypeptide) is another natural hormone that works alongside GLP-1
Meanwhile, on Tuesday, Novo announced that its triple-G agonist, UBT251, led to 19.7% weight loss after 24 weeks in a Phase 2 trial based in China
Lancet 373 , 492501 (2009)
diet alone failed to normalize the liver readouts to the same degree [3,4]
While there are varying perspectives on this issue, in a viewpoint that I was pleased to co-author with Sam Klein and Kevin Hall just published in JAMA, we suggest that the concern regarding physical frailty or sarcopenia with GLP-1-based medications may not be as grounded as some argue